nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoconazole—P-Glycoprotein Inhibitors—Lopinavir—acquired immunodeficiency syndrome	0.165	0.286	CiPCiCtD
Ketoconazole—Cytochrome P450 3A4 Inhibitors—Amprenavir—acquired immunodeficiency syndrome	0.129	0.223	CiPCiCtD
Ketoconazole—P-Glycoprotein Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.1	0.173	CiPCiCtD
Ketoconazole—Cytochrome P450 3A4 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.092	0.159	CiPCiCtD
Ketoconazole—Cytochrome P450 3A4 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.092	0.159	CiPCiCtD
Ketoconazole—CYP11A1—Saquinavir—acquired immunodeficiency syndrome	0.0213	0.0658	CbGbCtD
Ketoconazole—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.00917	0.0283	CbGbCtD
Ketoconazole—SLCO1A2—Indinavir—acquired immunodeficiency syndrome	0.00884	0.0273	CbGbCtD
Ketoconazole—SLCO1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00858	0.0265	CbGbCtD
Ketoconazole—SLCO1A2—Saquinavir—acquired immunodeficiency syndrome	0.00776	0.024	CbGbCtD
Ketoconazole—SLCO1A2—Ritonavir—acquired immunodeficiency syndrome	0.00776	0.024	CbGbCtD
Ketoconazole—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.00635	0.0196	CbGbCtD
Ketoconazole—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.00603	0.0186	CbGbCtD
Ketoconazole—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.00597	0.0184	CbGbCtD
Ketoconazole—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.00597	0.0184	CbGbCtD
Ketoconazole—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.00567	0.0175	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.00567	0.0175	CbGbCtD
Ketoconazole—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0054	0.0167	CbGbCtD
Ketoconazole—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.00489	0.0151	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.00489	0.0151	CbGbCtD
Ketoconazole—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.00475	0.0147	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.00475	0.0147	CbGbCtD
Ketoconazole—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0047	0.0145	CbGbCtD
Ketoconazole—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.00452	0.014	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.0043	0.0133	CbGbCtD
Ketoconazole—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.0043	0.0133	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.0043	0.0133	CbGbCtD
Ketoconazole—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.0043	0.0133	CbGbCtD
Ketoconazole—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00425	0.0131	CbGbCtD
Ketoconazole—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.00425	0.0131	CbGbCtD
Ketoconazole—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00409	0.0126	CbGbCtD
Ketoconazole—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.00409	0.0126	CbGbCtD
Ketoconazole—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00409	0.0126	CbGbCtD
Ketoconazole—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00403	0.0125	CbGbCtD
Ketoconazole—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00379	0.0117	CbGbCtD
Ketoconazole—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.00372	0.0115	CbGbCtD
Ketoconazole—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00367	0.0113	CbGbCtD
Ketoconazole—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00356	0.011	CbGbCtD
Ketoconazole—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0035	0.0108	CbGbCtD
Ketoconazole—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0035	0.0108	CbGbCtD
Ketoconazole—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.00343	0.0106	CbGbCtD
Ketoconazole—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00343	0.0106	CbGbCtD
Ketoconazole—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00335	0.0104	CbGbCtD
Ketoconazole—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00322	0.00995	CbGbCtD
Ketoconazole—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00322	0.00995	CbGbCtD
Ketoconazole—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.00317	0.00978	CbGbCtD
Ketoconazole—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00315	0.00974	CbGbCtD
Ketoconazole—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00315	0.00974	CbGbCtD
Ketoconazole—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0031	0.00957	CbGbCtD
Ketoconazole—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0031	0.00957	CbGbCtD
Ketoconazole—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.00307	0.00947	CbGbCtD
Ketoconazole—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00306	0.00945	CbGbCtD
Ketoconazole—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00297	0.00918	CbGbCtD
Ketoconazole—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00296	0.00915	CbGbCtD
Ketoconazole—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00288	0.00891	CbGbCtD
Ketoconazole—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00288	0.00891	CbGbCtD
Ketoconazole—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00287	0.00888	CbGbCtD
Ketoconazole—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.00285	0.00881	CbGbCtD
Ketoconazole—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00285	0.00881	CbGbCtD
Ketoconazole—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.00277	0.00855	CbGbCtD
Ketoconazole—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.00265	0.00819	CbGbCtD
Ketoconazole—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00261	0.00806	CbGbCtD
Ketoconazole—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00261	0.00806	CbGbCtD
Ketoconazole—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0026	0.00803	CbGbCtD
Ketoconazole—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0026	0.00803	CbGbCtD
Ketoconazole—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00249	0.0077	CbGbCtD
Ketoconazole—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00246	0.0076	CbGbCtD
Ketoconazole—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0024	0.00741	CbGbCtD
Ketoconazole—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00239	0.00738	CbGbCtD
Ketoconazole—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00239	0.00738	CbGbCtD
Ketoconazole—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00232	0.00716	CbGbCtD
Ketoconazole—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00225	0.00695	CbGbCtD
Ketoconazole—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00219	0.00675	CbGbCtD
Ketoconazole—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00216	0.00668	CbGbCtD
Ketoconazole—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00216	0.00668	CbGbCtD
Ketoconazole—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0021	0.00648	CbGbCtD
Ketoconazole—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0021	0.00648	CbGbCtD
Ketoconazole—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00207	0.0064	CbGbCtD
Ketoconazole—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00201	0.00621	CbGbCtD
Ketoconazole—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00198	0.0061	CbGbCtD
Ketoconazole—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00198	0.0061	CbGbCtD
Ketoconazole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00195	0.00602	CbGbCtD
Ketoconazole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00183	0.00566	CbGbCtD
Ketoconazole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00183	0.00566	CbGbCtD
Ketoconazole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00166	0.00512	CbGbCtD
Ketoconazole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.00512	CbGbCtD
Ketoconazole—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00156	0.00481	CbGbCtD
Ketoconazole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00143	0.00442	CbGbCtD
Ketoconazole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00139	0.00429	CbGbCtD
Ketoconazole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00126	0.00388	CbGbCtD
Ketoconazole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00126	0.00388	CbGbCtD
Ketoconazole—CYP19A1—semen—acquired immunodeficiency syndrome	0.00122	0.0573	CbGeAlD
Ketoconazole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0012	0.00372	CbGbCtD
Ketoconazole—CYP11B2—blood plasma—acquired immunodeficiency syndrome	0.0012	0.0566	CbGeAlD
Ketoconazole—AR—semen—acquired immunodeficiency syndrome	0.00108	0.0508	CbGeAlD
Ketoconazole—CYP27B1—vagina—acquired immunodeficiency syndrome	0.000574	0.027	CbGeAlD
Ketoconazole—CYP24A1—digestive system—acquired immunodeficiency syndrome	0.00045	0.0212	CbGeAlD
Ketoconazole—CYP11B1—blood—acquired immunodeficiency syndrome	0.000441	0.0207	CbGeAlD
Ketoconazole—CYP11B2—blood—acquired immunodeficiency syndrome	0.000441	0.0207	CbGeAlD
Ketoconazole—CYP26A1—brain—acquired immunodeficiency syndrome	0.000431	0.0203	CbGeAlD
Ketoconazole—CYP24A1—vagina—acquired immunodeficiency syndrome	0.000398	0.0187	CbGeAlD
Ketoconazole—CYP51A1—lung—acquired immunodeficiency syndrome	0.000394	0.0185	CbGeAlD
Ketoconazole—CYP24A1—lung—acquired immunodeficiency syndrome	0.000376	0.0177	CbGeAlD
Ketoconazole—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000365	0.0171	CbGeAlD
Ketoconazole—ABCB11—digestive system—acquired immunodeficiency syndrome	0.000321	0.0151	CbGeAlD
Ketoconazole—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000318	0.015	CbGeAlD
Ketoconazole—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000298	0.014	CbGeAlD
Ketoconazole—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000287	0.0135	CbGeAlD
Ketoconazole—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000285	0.0134	CbGeAlD
Ketoconazole—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000283	0.0133	CbGeAlD
Ketoconazole—CYP51A1—brain—acquired immunodeficiency syndrome	0.000279	0.0131	CbGeAlD
Ketoconazole—CYP11B2—lymph node—acquired immunodeficiency syndrome	0.000264	0.0124	CbGeAlD
Ketoconazole—CYP11A1—blood—acquired immunodeficiency syndrome	0.000251	0.0118	CbGeAlD
Ketoconazole—CYP17A1—nervous system—acquired immunodeficiency syndrome	0.000219	0.0103	CbGeAlD
Ketoconazole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000216	0.0101	CbGeAlD
Ketoconazole—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000212	0.00997	CbGeAlD
Ketoconazole—CYP17A1—central nervous system—acquired immunodeficiency syndrome	0.000211	0.0099	CbGeAlD
Ketoconazole—CYP11A1—nervous system—acquired immunodeficiency syndrome	0.000203	0.00957	CbGeAlD
Ketoconazole—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.0002	0.00939	CbGeAlD
Ketoconazole—CYP11A1—central nervous system—acquired immunodeficiency syndrome	0.000196	0.00921	CbGeAlD
Ketoconazole—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000193	0.00905	CbGeAlD
Ketoconazole—AR—skin of body—acquired immunodeficiency syndrome	0.000189	0.00889	CbGeAlD
Ketoconazole—CYP2A6—lung—acquired immunodeficiency syndrome	0.000182	0.00856	CbGeAlD
Ketoconazole—SLCO1A2—digestive system—acquired immunodeficiency syndrome	0.000175	0.00823	CbGeAlD
Ketoconazole—CYP17A1—brain—acquired immunodeficiency syndrome	0.000167	0.00786	CbGeAlD
Ketoconazole—CYP19A1—blood—acquired immunodeficiency syndrome	0.000163	0.00766	CbGeAlD
Ketoconazole—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000162	0.00761	CbGeAlD
Ketoconazole—CYP17A1—lymph node—acquired immunodeficiency syndrome	0.000162	0.00759	CbGeAlD
Ketoconazole—SLCO1A2—spinal cord—acquired immunodeficiency syndrome	0.000161	0.00756	CbGeAlD
Ketoconazole—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.00016	0.00751	CbGeAlD
Ketoconazole—CYP11A1—brain—acquired immunodeficiency syndrome	0.000156	0.00731	CbGeAlD
Ketoconazole—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.000153	0.0072	CbGeAlD
Ketoconazole—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000153	0.00717	CbGeAlD
Ketoconazole—CYP1B1—blood—acquired immunodeficiency syndrome	0.000152	0.00716	CbGeAlD
Ketoconazole—AR—digestive system—acquired immunodeficiency syndrome	0.000151	0.00711	CbGeAlD
Ketoconazole—CYP11A1—lymph node—acquired immunodeficiency syndrome	0.00015	0.00706	CbGeAlD
Ketoconazole—SLCO1A2—lung—acquired immunodeficiency syndrome	0.000146	0.00688	CbGeAlD
Ketoconazole—AR—blood—acquired immunodeficiency syndrome	0.000144	0.00678	CbGeAlD
Ketoconazole—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000141	0.00664	CbGeAlD
Ketoconazole—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.00014	0.00659	CbGeAlD
Ketoconazole—AR—spinal cord—acquired immunodeficiency syndrome	0.000139	0.00653	CbGeAlD
Ketoconazole—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000137	0.00645	CbGeAlD
Ketoconazole—SLCO1A2—nervous system—acquired immunodeficiency syndrome	0.000135	0.00637	CbGeAlD
Ketoconazole—AR—vagina—acquired immunodeficiency syndrome	0.000134	0.00628	CbGeAlD
Ketoconazole—CYP2C19—blood—acquired immunodeficiency syndrome	0.000134	0.00628	CbGeAlD
Ketoconazole—CYP1B1—lung—acquired immunodeficiency syndrome	0.000133	0.00627	CbGeAlD
Ketoconazole—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.000132	0.00621	CbGeAlD
Ketoconazole—SLCO1A2—central nervous system—acquired immunodeficiency syndrome	0.00013	0.00613	CbGeAlD
Ketoconazole—CYP2A6—brain—acquired immunodeficiency syndrome	0.000129	0.00606	CbGeAlD
Ketoconazole—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.000127	0.00598	CbGeAlD
Ketoconazole—AR—lung—acquired immunodeficiency syndrome	0.000126	0.00594	CbGeAlD
Ketoconazole—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000124	0.00582	CbGeAlD
Ketoconazole—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000124	0.00581	CbGeAlD
Ketoconazole—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000119	0.00559	CbGeAlD
Ketoconazole—AR—nervous system—acquired immunodeficiency syndrome	0.000117	0.0055	CbGeAlD
Ketoconazole—CYP2C8—blood—acquired immunodeficiency syndrome	0.000117	0.00548	CbGeAlD
Ketoconazole—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000115	0.00538	CbGeAlD
Ketoconazole—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000113	0.00531	CbGeAlD
Ketoconazole—AR—central nervous system—acquired immunodeficiency syndrome	0.000113	0.0053	CbGeAlD
Ketoconazole—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000111	0.00522	CbGeAlD
Ketoconazole—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.00011	0.00519	CbGeAlD
Ketoconazole—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.00011	0.00516	CbGeAlD
Ketoconazole—CYP1A2—blood—acquired immunodeficiency syndrome	0.000109	0.00513	CbGeAlD
Ketoconazole—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000109	0.00511	CbGeAlD
Ketoconazole—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000108	0.00508	CbGeAlD
Ketoconazole—CYP1A1—blood—acquired immunodeficiency syndrome	0.000108	0.00506	CbGeAlD
Ketoconazole—CYP3A5—blood—acquired immunodeficiency syndrome	0.000105	0.00495	CbGeAlD
Ketoconazole—CYP2B6—blood—acquired immunodeficiency syndrome	0.000105	0.00492	CbGeAlD
Ketoconazole—CYP2C9—blood—acquired immunodeficiency syndrome	0.000104	0.00487	CbGeAlD
Ketoconazole—SLCO1A2—brain—acquired immunodeficiency syndrome	0.000104	0.00487	CbGeAlD
Ketoconazole—CYP19A1—brain—acquired immunodeficiency syndrome	0.000101	0.00475	CbGeAlD
Ketoconazole—CYP1A1—vagina—acquired immunodeficiency syndrome	9.98e-05	0.00469	CbGeAlD
Ketoconazole—CYP19A1—lymph node—acquired immunodeficiency syndrome	9.76e-05	0.00459	CbGeAlD
Ketoconazole—CYP3A5—vagina—acquired immunodeficiency syndrome	9.75e-05	0.00459	CbGeAlD
Ketoconazole—CYP2B6—vagina—acquired immunodeficiency syndrome	9.69e-05	0.00456	CbGeAlD
Ketoconazole—CYP1A2—lung—acquired immunodeficiency syndrome	9.56e-05	0.0045	CbGeAlD
Ketoconazole—CYP1B1—brain—acquired immunodeficiency syndrome	9.45e-05	0.00444	CbGeAlD
Ketoconazole—CYP1A1—lung—acquired immunodeficiency syndrome	9.43e-05	0.00444	CbGeAlD
Ketoconazole—CYP3A5—lung—acquired immunodeficiency syndrome	9.22e-05	0.00434	CbGeAlD
Ketoconazole—CYP2B6—lung—acquired immunodeficiency syndrome	9.17e-05	0.00431	CbGeAlD
Ketoconazole—CYP1B1—lymph node—acquired immunodeficiency syndrome	9.13e-05	0.00429	CbGeAlD
Ketoconazole—AR—brain—acquired immunodeficiency syndrome	8.95e-05	0.00421	CbGeAlD
Ketoconazole—CYP1A1—nervous system—acquired immunodeficiency syndrome	8.74e-05	0.00411	CbGeAlD
Ketoconazole—AR—lymph node—acquired immunodeficiency syndrome	8.64e-05	0.00406	CbGeAlD
Ketoconazole—CYP2B6—nervous system—acquired immunodeficiency syndrome	8.49e-05	0.00399	CbGeAlD
Ketoconazole—CYP1A1—central nervous system—acquired immunodeficiency syndrome	8.41e-05	0.00395	CbGeAlD
Ketoconazole—ABCB1—retina—acquired immunodeficiency syndrome	8.36e-05	0.00393	CbGeAlD
Ketoconazole—CYP3A4—digestive system—acquired immunodeficiency syndrome	8.29e-05	0.0039	CbGeAlD
Ketoconazole—CYP2B6—central nervous system—acquired immunodeficiency syndrome	8.17e-05	0.00384	CbGeAlD
Ketoconazole—CYP2D6—digestive system—acquired immunodeficiency syndrome	8.16e-05	0.00383	CbGeAlD
Ketoconazole—CYP3A4—blood—acquired immunodeficiency syndrome	7.9e-05	0.00371	CbGeAlD
Ketoconazole—CYP2D6—blood—acquired immunodeficiency syndrome	7.77e-05	0.00365	CbGeAlD
Ketoconazole—CYP2C8—brain—acquired immunodeficiency syndrome	7.23e-05	0.0034	CbGeAlD
Ketoconazole—Constipation—Zidovudine—acquired immunodeficiency syndrome	6.77e-05	0.000883	CcSEcCtD
Ketoconazole—Asthenia—Nevirapine—acquired immunodeficiency syndrome	6.77e-05	0.000883	CcSEcCtD
Ketoconazole—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	6.76e-05	0.000881	CcSEcCtD
Ketoconazole—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	6.75e-05	0.00088	CcSEcCtD
Ketoconazole—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	6.74e-05	0.000878	CcSEcCtD
Ketoconazole—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	6.74e-05	0.000878	CcSEcCtD
Ketoconazole—Nervousness—Lamivudine—acquired immunodeficiency syndrome	6.73e-05	0.000877	CcSEcCtD
Ketoconazole—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	6.71e-05	0.000875	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	6.71e-05	0.000875	CcSEcCtD
Ketoconazole—Pruritus—Nevirapine—acquired immunodeficiency syndrome	6.68e-05	0.00087	CcSEcCtD
Ketoconazole—CYP1A1—brain—acquired immunodeficiency syndrome	6.68e-05	0.00314	CbGeAlD
Ketoconazole—Vomiting—Didanosine—acquired immunodeficiency syndrome	6.67e-05	0.00087	CcSEcCtD
Ketoconazole—Insomnia—Indinavir—acquired immunodeficiency syndrome	6.66e-05	0.000868	CcSEcCtD
Ketoconazole—Anorexia—Efavirenz—acquired immunodeficiency syndrome	6.63e-05	0.000865	CcSEcCtD
Ketoconazole—Rash—Didanosine—acquired immunodeficiency syndrome	6.62e-05	0.000863	CcSEcCtD
Ketoconazole—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	6.61e-05	0.000862	CcSEcCtD
Ketoconazole—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	6.61e-05	0.000862	CcSEcCtD
Ketoconazole—Dermatitis—Didanosine—acquired immunodeficiency syndrome	6.61e-05	0.000862	CcSEcCtD
Ketoconazole—Headache—Didanosine—acquired immunodeficiency syndrome	6.58e-05	0.000857	CcSEcCtD
Ketoconazole—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	6.56e-05	0.000855	CcSEcCtD
Ketoconazole—Malaise—Saquinavir—acquired immunodeficiency syndrome	6.55e-05	0.000854	CcSEcCtD
Ketoconazole—Somnolence—Indinavir—acquired immunodeficiency syndrome	6.55e-05	0.000853	CcSEcCtD
Ketoconazole—Asthenia—Stavudine—acquired immunodeficiency syndrome	6.54e-05	0.000852	CcSEcCtD
Ketoconazole—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	6.53e-05	0.000851	CcSEcCtD
Ketoconazole—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	6.52e-05	0.00085	CcSEcCtD
Ketoconazole—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000847	CcSEcCtD
Ketoconazole—CYP2B6—brain—acquired immunodeficiency syndrome	6.49e-05	0.00305	CbGeAlD
Ketoconazole—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	6.48e-05	0.000845	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	6.48e-05	0.000844	CcSEcCtD
Ketoconazole—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	6.47e-05	0.000843	CcSEcCtD
Ketoconazole—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	6.47e-05	0.000843	CcSEcCtD
Ketoconazole—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	6.46e-05	0.000842	CcSEcCtD
Ketoconazole—CYP1A1—lymph node—acquired immunodeficiency syndrome	6.45e-05	0.00303	CbGeAlD
Ketoconazole—Pruritus—Stavudine—acquired immunodeficiency syndrome	6.45e-05	0.00084	CcSEcCtD
Ketoconazole—Asthenia—Abacavir—acquired immunodeficiency syndrome	6.44e-05	0.000839	CcSEcCtD
Ketoconazole—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	6.43e-05	0.000838	CcSEcCtD
Ketoconazole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	6.42e-05	0.000837	CcSEcCtD
Ketoconazole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	6.42e-05	0.000837	CcSEcCtD
Ketoconazole—CYP3A4—nervous system—acquired immunodeficiency syndrome	6.41e-05	0.00301	CbGeAlD
Ketoconazole—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	6.4e-05	0.000835	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	6.38e-05	0.000831	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	6.36e-05	0.000829	CcSEcCtD
Ketoconazole—Pruritus—Abacavir—acquired immunodeficiency syndrome	6.35e-05	0.000828	CcSEcCtD
Ketoconazole—Fatigue—Indinavir—acquired immunodeficiency syndrome	6.35e-05	0.000828	CcSEcCtD
Ketoconazole—Anorexia—Delavirdine—acquired immunodeficiency syndrome	6.35e-05	0.000827	CcSEcCtD
Ketoconazole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	6.35e-05	0.000827	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	6.34e-05	0.000826	CcSEcCtD
Ketoconazole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	6.33e-05	0.000825	CcSEcCtD
Ketoconazole—CYP2D6—nervous system—acquired immunodeficiency syndrome	6.31e-05	0.00297	CbGeAlD
Ketoconazole—Constipation—Indinavir—acquired immunodeficiency syndrome	6.3e-05	0.000821	CcSEcCtD
Ketoconazole—Pain—Indinavir—acquired immunodeficiency syndrome	6.3e-05	0.000821	CcSEcCtD
Ketoconazole—Insomnia—Efavirenz—acquired immunodeficiency syndrome	6.3e-05	0.00082	CcSEcCtD
Ketoconazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	6.29e-05	0.00082	CcSEcCtD
Ketoconazole—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	6.28e-05	0.000819	CcSEcCtD
Ketoconazole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	6.26e-05	0.000816	CcSEcCtD
Ketoconazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	6.26e-05	0.000816	CcSEcCtD
Ketoconazole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	6.25e-05	0.000815	CcSEcCtD
Ketoconazole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	6.25e-05	0.000814	CcSEcCtD
Ketoconazole—Malaise—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.000814	CcSEcCtD
Ketoconazole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	6.24e-05	0.000813	CcSEcCtD
Ketoconazole—Nausea—Didanosine—acquired immunodeficiency syndrome	6.24e-05	0.000813	CcSEcCtD
Ketoconazole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	6.2e-05	0.000808	CcSEcCtD
Ketoconazole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	6.19e-05	0.000806	CcSEcCtD
Ketoconazole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	6.18e-05	0.000806	CcSEcCtD
Ketoconazole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	6.18e-05	0.000806	CcSEcCtD
Ketoconazole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	6.17e-05	0.0029	CbGeAlD
Ketoconazole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	6.14e-05	0.000801	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	6.14e-05	0.0008	CcSEcCtD
Ketoconazole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	6.13e-05	0.000798	CcSEcCtD
Ketoconazole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	6.11e-05	0.000796	CcSEcCtD
Ketoconazole—CYP2D6—central nervous system—acquired immunodeficiency syndrome	6.07e-05	0.00286	CbGeAlD
Ketoconazole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	6.07e-05	0.000791	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000791	CcSEcCtD
Ketoconazole—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	6.05e-05	0.000789	CcSEcCtD
Ketoconazole—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	6.05e-05	0.000788	CcSEcCtD
Ketoconazole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	6.05e-05	0.000788	CcSEcCtD
Ketoconazole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	6.04e-05	0.000787	CcSEcCtD
Ketoconazole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	6.03e-05	0.000786	CcSEcCtD
Ketoconazole—Dizziness—Stavudine—acquired immunodeficiency syndrome	6.03e-05	0.000785	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	6.02e-05	0.000785	CcSEcCtD
Ketoconazole—Insomnia—Delavirdine—acquired immunodeficiency syndrome	6.02e-05	0.000785	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	6.01e-05	0.000783	CcSEcCtD
Ketoconazole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6e-05	0.000782	CcSEcCtD
Ketoconazole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6e-05	0.000782	CcSEcCtD
Ketoconazole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	5.98e-05	0.00078	CcSEcCtD
Ketoconazole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	5.98e-05	0.000779	CcSEcCtD
Ketoconazole—Constipation—Efavirenz—acquired immunodeficiency syndrome	5.95e-05	0.000776	CcSEcCtD
Ketoconazole—Pain—Efavirenz—acquired immunodeficiency syndrome	5.95e-05	0.000776	CcSEcCtD
Ketoconazole—Rash—Nevirapine—acquired immunodeficiency syndrome	5.95e-05	0.000776	CcSEcCtD
Ketoconazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	5.95e-05	0.000775	CcSEcCtD
Ketoconazole—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	5.94e-05	0.00279	CbGeAlD
Ketoconazole—Dizziness—Abacavir—acquired immunodeficiency syndrome	5.94e-05	0.000774	CcSEcCtD
Ketoconazole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	5.92e-05	0.000772	CcSEcCtD
Ketoconazole—Headache—Nevirapine—acquired immunodeficiency syndrome	5.91e-05	0.000771	CcSEcCtD
Ketoconazole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.000769	CcSEcCtD
Ketoconazole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.000769	CcSEcCtD
Ketoconazole—Anorexia—Ritonavir—acquired immunodeficiency syndrome	5.87e-05	0.000765	CcSEcCtD
Ketoconazole—ABCB1—digestive system—acquired immunodeficiency syndrome	5.87e-05	0.00276	CbGeAlD
Ketoconazole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	5.86e-05	0.000764	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	5.86e-05	0.000763	CcSEcCtD
Ketoconazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	5.85e-05	0.000763	CcSEcCtD
Ketoconazole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	5.83e-05	0.00076	CcSEcCtD
Ketoconazole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	5.82e-05	0.000759	CcSEcCtD
Ketoconazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	5.82e-05	0.000759	CcSEcCtD
Ketoconazole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	5.81e-05	0.000758	CcSEcCtD
Ketoconazole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	5.81e-05	0.000757	CcSEcCtD
Ketoconazole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	5.8e-05	0.000756	CcSEcCtD
Ketoconazole—Vomiting—Stavudine—acquired immunodeficiency syndrome	5.79e-05	0.000755	CcSEcCtD
Ketoconazole—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	5.79e-05	0.000754	CcSEcCtD
Ketoconazole—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	5.77e-05	0.000752	CcSEcCtD
Ketoconazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	5.76e-05	0.000751	CcSEcCtD
Ketoconazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	5.76e-05	0.00075	CcSEcCtD
Ketoconazole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	5.76e-05	0.00075	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	5.75e-05	0.000749	CcSEcCtD
Ketoconazole—Rash—Stavudine—acquired immunodeficiency syndrome	5.75e-05	0.000749	CcSEcCtD
Ketoconazole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	5.74e-05	0.000748	CcSEcCtD
Ketoconazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	5.74e-05	0.000748	CcSEcCtD
Ketoconazole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	5.74e-05	0.000747	CcSEcCtD
Ketoconazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	5.73e-05	0.000746	CcSEcCtD
Ketoconazole—Headache—Stavudine—acquired immunodeficiency syndrome	5.71e-05	0.000744	CcSEcCtD
Ketoconazole—Vomiting—Abacavir—acquired immunodeficiency syndrome	5.71e-05	0.000744	CcSEcCtD
Ketoconazole—Pain—Delavirdine—acquired immunodeficiency syndrome	5.69e-05	0.000742	CcSEcCtD
Ketoconazole—Constipation—Delavirdine—acquired immunodeficiency syndrome	5.69e-05	0.000742	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	5.69e-05	0.000742	CcSEcCtD
Ketoconazole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	5.68e-05	0.000741	CcSEcCtD
Ketoconazole—Rash—Abacavir—acquired immunodeficiency syndrome	5.66e-05	0.000738	CcSEcCtD
Ketoconazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	5.66e-05	0.000737	CcSEcCtD
Ketoconazole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	5.65e-05	0.000737	CcSEcCtD
Ketoconazole—Anorexia—Saquinavir—acquired immunodeficiency syndrome	5.65e-05	0.000736	CcSEcCtD
Ketoconazole—Headache—Abacavir—acquired immunodeficiency syndrome	5.62e-05	0.000733	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.61e-05	0.000731	CcSEcCtD
Ketoconazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.61e-05	0.000731	CcSEcCtD
Ketoconazole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	5.6e-05	0.00073	CcSEcCtD
Ketoconazole—ABCB1—blood—acquired immunodeficiency syndrome	5.59e-05	0.00263	CbGeAlD
Ketoconazole—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.57e-05	0.000726	CcSEcCtD
Ketoconazole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.55e-05	0.000723	CcSEcCtD
Ketoconazole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	5.54e-05	0.000722	CcSEcCtD
Ketoconazole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.53e-05	0.000721	CcSEcCtD
Ketoconazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	5.53e-05	0.000721	CcSEcCtD
Ketoconazole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.5e-05	0.000717	CcSEcCtD
Ketoconazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	5.5e-05	0.000717	CcSEcCtD
Ketoconazole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	5.49e-05	0.000716	CcSEcCtD
Ketoconazole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.49e-05	0.000715	CcSEcCtD
Ketoconazole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	5.47e-05	0.000713	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	5.45e-05	0.00071	CcSEcCtD
Ketoconazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	5.43e-05	0.000708	CcSEcCtD
Ketoconazole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	5.43e-05	0.000707	CcSEcCtD
Ketoconazole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	5.42e-05	0.000706	CcSEcCtD
Ketoconazole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.42e-05	0.000706	CcSEcCtD
Ketoconazole—Nausea—Stavudine—acquired immunodeficiency syndrome	5.41e-05	0.000705	CcSEcCtD
Ketoconazole—ABCB1—bone marrow—acquired immunodeficiency syndrome	5.41e-05	0.00254	CbGeAlD
Ketoconazole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.4e-05	0.000704	CcSEcCtD
Ketoconazole—Anorexia—Lamivudine—acquired immunodeficiency syndrome	5.39e-05	0.000702	CcSEcCtD
Ketoconazole—ABCB1—spinal cord—acquired immunodeficiency syndrome	5.39e-05	0.00253	CbGeAlD
Ketoconazole—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.36e-05	0.000699	CcSEcCtD
Ketoconazole—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.35e-05	0.000698	CcSEcCtD
Ketoconazole—Nausea—Abacavir—acquired immunodeficiency syndrome	5.33e-05	0.000695	CcSEcCtD
Ketoconazole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.32e-05	0.000694	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.32e-05	0.000693	CcSEcCtD
Ketoconazole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.31e-05	0.000692	CcSEcCtD
Ketoconazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.29e-05	0.000689	CcSEcCtD
Ketoconazole—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.29e-05	0.000689	CcSEcCtD
Ketoconazole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.27e-05	0.000687	CcSEcCtD
Ketoconazole—Pain—Ritonavir—acquired immunodeficiency syndrome	5.27e-05	0.000686	CcSEcCtD
Ketoconazole—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.27e-05	0.000686	CcSEcCtD
Ketoconazole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.26e-05	0.000686	CcSEcCtD
Ketoconazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.26e-05	0.000686	CcSEcCtD
Ketoconazole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.24e-05	0.000683	CcSEcCtD
Ketoconazole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.22e-05	0.00068	CcSEcCtD
Ketoconazole—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.21e-05	0.000679	CcSEcCtD
Ketoconazole—ABCB1—vagina—acquired immunodeficiency syndrome	5.18e-05	0.00244	CbGeAlD
Ketoconazole—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	5.15e-05	0.000672	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	5.15e-05	0.000671	CcSEcCtD
Ketoconazole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.13e-05	0.000668	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	5.12e-05	0.000667	CcSEcCtD
Ketoconazole—Insomnia—Lamivudine—acquired immunodeficiency syndrome	5.11e-05	0.000667	CcSEcCtD
Ketoconazole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.11e-05	0.000666	CcSEcCtD
Ketoconazole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.08e-05	0.000662	CcSEcCtD
Ketoconazole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.07e-05	0.000661	CcSEcCtD
Ketoconazole—Pain—Saquinavir—acquired immunodeficiency syndrome	5.07e-05	0.000661	CcSEcCtD
Ketoconazole—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.07e-05	0.000661	CcSEcCtD
Ketoconazole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.04e-05	0.000657	CcSEcCtD
Ketoconazole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.04e-05	0.000656	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.04e-05	0.000656	CcSEcCtD
Ketoconazole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.03e-05	0.000655	CcSEcCtD
Ketoconazole—Rash—Zidovudine—acquired immunodeficiency syndrome	4.99e-05	0.000651	CcSEcCtD
Ketoconazole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	4.99e-05	0.000651	CcSEcCtD
Ketoconazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	4.99e-05	0.00065	CcSEcCtD
Ketoconazole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	4.98e-05	0.000649	CcSEcCtD
Ketoconazole—Headache—Zidovudine—acquired immunodeficiency syndrome	4.96e-05	0.000647	CcSEcCtD
Ketoconazole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	4.92e-05	0.000642	CcSEcCtD
Ketoconazole—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	4.92e-05	0.000641	CcSEcCtD
Ketoconazole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	4.91e-05	0.000639	CcSEcCtD
Ketoconazole—ABCB1—lung—acquired immunodeficiency syndrome	4.9e-05	0.0023	CbGeAlD
Ketoconazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	4.89e-05	0.000638	CcSEcCtD
Ketoconazole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	4.88e-05	0.000637	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	4.88e-05	0.000636	CcSEcCtD
Ketoconazole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	4.88e-05	0.000635	CcSEcCtD
Ketoconazole—Dizziness—Indinavir—acquired immunodeficiency syndrome	4.87e-05	0.000635	CcSEcCtD
Ketoconazole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	4.87e-05	0.000634	CcSEcCtD
Ketoconazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	4.87e-05	0.000634	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	4.85e-05	0.000632	CcSEcCtD
Ketoconazole—Pain—Lamivudine—acquired immunodeficiency syndrome	4.84e-05	0.00063	CcSEcCtD
Ketoconazole—Constipation—Lamivudine—acquired immunodeficiency syndrome	4.84e-05	0.00063	CcSEcCtD
Ketoconazole—CYP2D6—brain—acquired immunodeficiency syndrome	4.82e-05	0.00227	CbGeAlD
Ketoconazole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	4.78e-05	0.000623	CcSEcCtD
Ketoconazole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	4.76e-05	0.000621	CcSEcCtD
Ketoconazole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	4.71e-05	0.000614	CcSEcCtD
Ketoconazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	4.71e-05	0.000614	CcSEcCtD
Ketoconazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.71e-05	0.000613	CcSEcCtD
Ketoconazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.69e-05	0.000611	CcSEcCtD
Ketoconazole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.69e-05	0.000611	CcSEcCtD
Ketoconazole—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.68e-05	0.00061	CcSEcCtD
Ketoconazole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.66e-05	0.000607	CcSEcCtD
Ketoconazole—Rash—Indinavir—acquired immunodeficiency syndrome	4.64e-05	0.000605	CcSEcCtD
Ketoconazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.64e-05	0.000605	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.62e-05	0.000603	CcSEcCtD
Ketoconazole—Headache—Indinavir—acquired immunodeficiency syndrome	4.62e-05	0.000601	CcSEcCtD
Ketoconazole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.6e-05	0.0006	CcSEcCtD
Ketoconazole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.56e-05	0.000594	CcSEcCtD
Ketoconazole—ABCB1—nervous system—acquired immunodeficiency syndrome	4.54e-05	0.00213	CbGeAlD
Ketoconazole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	4.54e-05	0.000591	CcSEcCtD
Ketoconazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.49e-05	0.000585	CcSEcCtD
Ketoconazole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.47e-05	0.000583	CcSEcCtD
Ketoconazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.47e-05	0.000583	CcSEcCtD
Ketoconazole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.43e-05	0.000577	CcSEcCtD
Ketoconazole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.42e-05	0.000576	CcSEcCtD
Ketoconazole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.4e-05	0.000574	CcSEcCtD
Ketoconazole—Rash—Efavirenz—acquired immunodeficiency syndrome	4.39e-05	0.000572	CcSEcCtD
Ketoconazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.38e-05	0.000571	CcSEcCtD
Ketoconazole—Nausea—Indinavir—acquired immunodeficiency syndrome	4.38e-05	0.00057	CcSEcCtD
Ketoconazole—ABCB1—central nervous system—acquired immunodeficiency syndrome	4.37e-05	0.00205	CbGeAlD
Ketoconazole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.37e-05	0.000569	CcSEcCtD
Ketoconazole—Headache—Efavirenz—acquired immunodeficiency syndrome	4.36e-05	0.000568	CcSEcCtD
Ketoconazole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.36e-05	0.000568	CcSEcCtD
Ketoconazole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.25e-05	0.000554	CcSEcCtD
Ketoconazole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.23e-05	0.000552	CcSEcCtD
Ketoconazole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.21e-05	0.000549	CcSEcCtD
Ketoconazole—Rash—Delavirdine—acquired immunodeficiency syndrome	4.2e-05	0.000547	CcSEcCtD
Ketoconazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.2e-05	0.000547	CcSEcCtD
Ketoconazole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.19e-05	0.000547	CcSEcCtD
Ketoconazole—Headache—Delavirdine—acquired immunodeficiency syndrome	4.17e-05	0.000544	CcSEcCtD
Ketoconazole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.17e-05	0.000543	CcSEcCtD
Ketoconazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.13e-05	0.000539	CcSEcCtD
Ketoconazole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.07e-05	0.000531	CcSEcCtD
Ketoconazole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.06e-05	0.000529	CcSEcCtD
Ketoconazole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.06e-05	0.000529	CcSEcCtD
Ketoconazole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4e-05	0.000521	CcSEcCtD
Ketoconazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.96e-05	0.000516	CcSEcCtD
Ketoconazole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	3.92e-05	0.000511	CcSEcCtD
Ketoconazole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.92e-05	0.00051	CcSEcCtD
Ketoconazole—Rash—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000506	CcSEcCtD
Ketoconazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000506	CcSEcCtD
Ketoconazole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.87e-05	0.000504	CcSEcCtD
Ketoconazole—Headache—Ritonavir—acquired immunodeficiency syndrome	3.86e-05	0.000503	CcSEcCtD
Ketoconazole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.77e-05	0.000491	CcSEcCtD
Ketoconazole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.74e-05	0.000487	CcSEcCtD
Ketoconazole—Rash—Saquinavir—acquired immunodeficiency syndrome	3.74e-05	0.000487	CcSEcCtD
Ketoconazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000487	CcSEcCtD
Ketoconazole—Headache—Saquinavir—acquired immunodeficiency syndrome	3.71e-05	0.000484	CcSEcCtD
Ketoconazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.66e-05	0.000477	CcSEcCtD
Ketoconazole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.6e-05	0.000469	CcSEcCtD
Ketoconazole—Rash—Lamivudine—acquired immunodeficiency syndrome	3.57e-05	0.000465	CcSEcCtD
Ketoconazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000464	CcSEcCtD
Ketoconazole—Headache—Lamivudine—acquired immunodeficiency syndrome	3.54e-05	0.000462	CcSEcCtD
Ketoconazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.52e-05	0.000459	CcSEcCtD
Ketoconazole—ABCB1—brain—acquired immunodeficiency syndrome	3.47e-05	0.00163	CbGeAlD
Ketoconazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.36e-05	0.000438	CcSEcCtD
Ketoconazole—ABCB1—lymph node—acquired immunodeficiency syndrome	3.35e-05	0.00158	CbGeAlD
